S-Adenosylmethionine (AdoMet) plays a myriad of roles in cellular metabolism. One of the many roles of AdoMet in Escherichia coli and Salmonella typhimurium is as a corepressor of genes encoding enzymes of methionine biosynthesis. To investigate the metabolic effects of large reductions in intracellular AdoMet concentrations in growing cells, we constructed and examined mutants of E. coli which are conditionally defective in AdoMet synthesis. Temperature-sensitive mutants in metK, the structural gene for the Sadenosylmethionine synthetase (AdoMet synthetase) expressed in minimal medium, were constructed by in vitro mutagenesis of a plasmid-borne copy of metK. By homologous recombination, the chromosomal copy was replaced with the mutated metK gene. Both heatand cold-sensitive mutants were examined. At the nonpermissive temperature, two such mutants had 200-fold-reduced intracellular AdoMet levels and required either methionine or vitamin B12 for growth. In the presence of methionine or vitamin B12, the mutants grew at normal rates even though the AdoMet levels remained 0.5% of wild type. A third mutant when placed at nonpermissive temperature had <0.2% of the normal AdoMet level and did not grow on minimal medium even in the presence of methionine or vitamin B12. All of these mutants grew normally on yeast-extract-based medium in which an alternate form of S-adenosylmethionine synthetase was expressed.
reported mutants have maximally fourfold-reduced intracellular AdoMet levels, apparently as a result of production of partially active AdoMet synthetases (9-11, 16-18, 27) . These metK mutants were isolated as strains resistant to methionine analogs added to the growth medium. Although the metK mutants that have so far been isolated are derepressed for production of the enzymes of methionine biosynthesis, it is surprising that the change in total intracellular AdoMet concentration is relatively small. We therefore set out to construct temperature-dependent null mutants of metK to verify and reevaluate the roles of AdoMet and AdoMet synthetase in various cellular processes. Through use of in vitro mutagenesis of the cloned metK gene and gene replacement methods, we have prepared and characterized new metK mutants. These mutants have dramatic temperaturedependent reductions in both intracellular AdoMet synthetase and AdoMet levels and display novel growth behavior.
MATERUILS AND METHODS
The medium components for Vogel-Bonner minimal medium (33) and LB rich medium (20) were purchased from * Corresponding author. Sigma Chemical Co. and Difco Laboratories, respectively. When present, amino acids were added at 0.01% (wt/vol) and vitamin B12 was added at 0.0002%. Biochemicals were purchased from Sigma Chemical Co. Commercial AdoMet was purified before use as described previously (7) . Molecular biology reagents were obtained from New England BioLabs or Bethesda Research Laboratories. Other reagents were obtained from commercial sources.
Strains and plasmids. The strains and plasmids used and their sources are listed in Table 1. Molecular biology methods. Recombinant DNA methods used protocols recommended by the suppliers of the enzymes and other standard procedures (20) .
Construction of a metK-containing plasmid for mutagenesis. The plasmid used for mutagenesis and the subsequent gene replacement steps, pKA13Kan ( Fig. 1 ), was derived in two steps from the previously described pKA12 (3) . pKA12 is a pBR322 derivative which contains metK, the speA gene which is upstream from metK, and -600 base pairs of DNA downstream from metK. pKA13 was obtained by deletion of a 2-kilobase-pair EcoRI fragment of pKA12, which removed part of the pBR322 vector and DNA sequences downstream from the speA gene. A selectable marker closely linked to metK was required for the gene replacement steps. Therefore, a kanamycin resistance cartridge from plasmid pUC4K (25) was inserted into a BamHI site 80 base pairs upstream from the start of the metK coding region (21) . Restriction maps verified the orientation of the kanamycin cartridge shown in Fig. 1 . The insertion of the kanamycin resistance cartridge had no significant effect on level of AdoMet synthetase activity present in strains carrying pKA13Kan versus pKA13.
In vitro mutagenesis. Plasmid pKA13Kan (6 ,ug) was mutagenized by treatment with 1 M hydroxylamine-1 mM EDTA, pH 6.0, for 45 min at 0°C, followed by incubation for 30 min at 70°C (15) . Subsequently, the hydroxylamine was removed by five cycles of concentration and dilution into 1 ml of 30 mM CaCl2, using an Amicon Centricon concentra-4490 SATISHCHANDRAN ET AL. tor; the mutagenized plasmid was finally placed in a volume of 0.2 ml of 30 mM CaCl2. Construction of chromosomal mutations. The mutations from each plasmid were transferred into the E. coli chromosome as described by Winans et al. (34) . DNA containing the metK region without an origin of replication was obtained by an EcoRI-BaIl double digest of the plasmids (Fig. 1) . The metK-containing DNA was isolated from agarose gels (1) and transformed into strain JC7623, a recBC sbcB strain which is readily transformed with linear DNA. In the absence of an origin of replication on the transforming DNA, all drug-resistant transformants have replaced the chromosomal DNA with the transforming DNA carrying the selectable marker. Transformants were plated on kanamycincontaining medium at the permissive temperature.
Mapping of chromosomal mutations. P1 vir lysates of the strains bearing each of the three chromosomal mutations were prepared, and transductions were carried out as described by Miller (26) .
Determination of AdoMet pools. Intracellular AdoMet levels were determined by ion-exchange high-performance liq-
Restriction map and gene organization in plasmid pKA13Kan. KAN and AMP represent the genes (kan and bla) that encode proteins that confer resistance to the antibiotics kanamycin and ampicillin, respectively. The origin of replication is represented as Ori, and the direction of transcription of the genes on the plasmid is shown. The gene encoding kanamycin resistance (kan) is inserted into pKA13 at the BamHl site upstream of the first codon of the metK gene. The originless EcoRI-Ball linear DNA fragment that contains speA, metK, and the gene for kanamycin resistance was used to transform E. coli JC7623 to replace the speA-metK region on the chromosome. Kb, Kilobase. uid chromatography with UV detection at 254 nm. A Whatman SCX column (0.46 by 25 cm) was attached to a Beckman 320 high-performance liquid chromatography system. The elution buffer contained 33.5 ml of concentrated NH40H per liter adjusted to pH 4.0 with formic acid.
Isocratic elution at 1.5 ml/min was used because this gave rapid (-15-min total time) chromatography suitable for quantitation of AdoMet levels. AdoMet eluted as a wellresolved peak at 8.2 ml. AdoMet levels were quantified by comparison of peak heights or areas (with equivalent results) to standard samples. Standards showed elution positions (in milliliters) for adenosine (4.0), S-adenosylhomocysteine (4.3), 5'-methylthioadenosine (6.0), and adenine (5.7).
Preparation of cell extracts for intracellular AdoMet pool determinations. Cells were harvested by centrifugation of cultures of known density. The cell pellet was extracted with 0.1 volume of cold 10% trichloroacetic acid. After centrifugation, the trichloroacetic acid was removed by three extractions with an equal volume of water-saturated diethyl ether.
Volumes between 25 and 250 [lI were injected onto the high-performance liquid chromatographic column without alteration of peak width or retention time; chromatograms were obtained in duplicate.
Preparation of cell extracts for enzyme assays. Cells were grown to stationary phase or as described in the figure legends and concentrated by centrifugation to 4 x 109 to 20 x 109 cells per ml. Cells were suspended in 50 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid)/KOH-50 mM KCl-0.1% 2-mercaptoethanol (pH 8.0) buffer and broken by sonication, using the microtip of a Branson sonicator (at 100 W for 6 min at 50% duty cycle). After removal of debris by centrifugation (10 min at 10,000 x g), aliquots were removed for AdoMet synthetase assays or for protein determination. Protein was determined by the method of Bradford (4) , using a kit from Bio-Rad; bovine serum albumin (BSA) was used as the standard. Enzyme assays. AdoMet synthetase assays monitored the incorporation of [14CH3]methionine (New England Nuclear)
into AdoMet as described previously (22) , except that the methionine concentration was 0.2 mM and the specific activity was 51.8 mCi/mmol. Whatman P81 ion-exchange filters were used to retain the AdoMet formed. Assays were conducted at 20 ± 2°C unless otherwise noted. The rate of AdoMet formation was determined by regression analysis of the data obtained by quenching aliquots of the reaction after various incubation times. Antibody production. AdoMet synthetase was purified from an overproducing clone harboring the metK-containing plasmid pKA8 (3), by the method of Markham et al. (22) . Antibodies were raised in guinea pigs by using purified S-adenosylmethionine synthetase (metK product) as the antigen. Preimmune sera were obtained from each animal prior to immunization. AdoMet synthetase, 0.15 mg in complete Freund adjuvant, was injected intradermally. After 6 weeks, the animals were injected with 0.15 mg of enzyme in incomplete Freund adjuvant. This was followed after 3 weeks by another injection of 0.1 mg of enzyme in incomplete Freund adjuvant. Antisera were obtained 2 weeks after the third injection. After removal of erythrocytes, the sera were stored in aliquots at -70°C. Antisera were used without further fractionation. Immunodiffusion analysis. Ouchterlony double-diffusion experiments were carried out as described before (30) , except that the 1% agarose contained 50 mM HEPES/ KOH-50 mM KCl (pH 8.0) instead of buffered saline.
SDS-PAGE. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed as described by McGrogan et al. (24) .
Immunoblotting. Immunologically cross-reactive protein bands were detected on immunoblots with the Vectastain ABC peroxidase kit obtained from Vector Laboratories. The kit was used as described by the supplier, with the following modifications. The SDS-polyacrylamide gel was laid against nitrocellulose (BA-85, 0.45 pum; Schleicher & Schuell) and electrophoresed in a Bio-Rad transblot apparatus for 4 h at 150 mA, using a buffer of 25 mM Tris, 193 mM glycine, and 10% methanol. The nitrocellulose filter was then soaked in 10 ml of BSA buffer (3% BSA, 0.9% NaCl, 10 mM Tris hydrochloride, pH 7.4) overnight at 4°C. To this solution -10 ,ul of anti-AdoMet synthetase antibody was added, and the filter was incubated on a rocking platform for -2 h at 25°C. Following six washes with distilled water (total time, -1 min), -100 ,ul of biotinylated anti-guinea pig immunoglobulin G (1.5 mg/ml) in BSA buffer was added, and the solution was allowed to mix for 1 h at 25°C. The filter was rinsed with distilled water as described above and then soaked in a mixture containing -100 ,ul each of solution A and solution B (vector ABC kit) in 5 ml of BSA buffer for 1 h at 25°C. Once again, the filter was washed with distilled water as described before, and 10 ,l of peroxidase substrate (0.6 mg of 4-chloro-1-naphthol per ml in methanol) and 10 ,ul of 30% H202 were added to the filter in 10 ml of BSA buffer.
RESULTS
Construction and characterization of plasmid-borne temperature-sensitive metK mutants. The strategy for obtaining plasmids with metK mutations relied on the use of a metG metK strain. A typical metG mutant (which has a mutation in methionyl-tRNA synthetase that results in a high Km for methionine) has a higher than normal requirement for methionine for growth and therefore is a methionine auxotroph. However, the chromosomal metK mutation causes derepression of the genes for the methionine biosynthetic enzymes, resulting in overproduction of methionine. Thus, a metG metK double mutant such as strain DM50 is a methionine prototroph (6). However, strain DM50 becomes a methio- nine auxotroph when it is transformed with a plasmid which provides a metK gene that is expressed even at the level of a single chromosomal equivalent copy.
Plasmid pKA13Kan ( Fig. 1) , which contains the metK and speA genes with a kanamycin resistance cartridge inserted in the intergenic region 80 base pairs upstream from the beginning of the metK coding region (see Materials and Methods), was mutagenized with hydroxylamine, and the treated plasmid was transformed into strain DM50 (metK metG). Transformants were selected at 30 and 42°C in the presence of methionine.
These transformants were checked for methionine requirement at both temperatures. Kanamycin-resistant transformants which were Met' at 30 and 42°C contained plasmids which did not produce a fully active AdoMet synthetase at the temperature used. Based on the levels of AdoMet synthetase present in DM50, the equivalent of at most -10% of the enzyme activity from a single copy of wild-type metK+ would allow transformants to grow in the absence of methionine, corresponding to a very low activity for the enzyme produced from metK on a multicopy plasmid. Several hundred transformants were tested for temperature sensitivity of the Met' phenotype. Three temperature-sensitive transformants were chosen for further study; these were denoted as pKAl3Kan(metK501), pKA13Kan(metK 502), and pKA13Kan(metK503). Plasmids pKA13Kan(metK 502) and pKA13Kan(metK503) allowed growth in the absence of methionine at 42°C, but not at 30°C, while plasmid pKA13Kan(metK501) allowed methionine-independent growth at 30 but not 42°C. Plasmids were isolated from these strains and were retransformed into DM50; the phenotypes of the resulting strains were the same as the original isolates, indicating that the temperature sensitivity was associated with the plasmid.
To characterize the mutations, the plasmids were transformed into strain JC7623. AdoMet synthetase levels were determined for strain JC7623 lacking plasmid, containing the unmutagenized plasmid pKA13Kan, and those containing the three plasmids with putative metK mutations grown in the presence of methionine at 30 and 42°C ( Table 2) . Strain JC7623 was chosen since it was also used in studies of these mutations when present on the chromosome. At the nonpermissive temperature, the AdoMet synthetase activities in the extracts of the strains containing the plasmid-borne mutant metK were indistinguishable from JC7623 lacking a metK plasmid and were -6% of the level of JC7623(pKA13Kan). At permissive temperatures, the AdoMet synthetase activi- VOL. 172, 1990 SATISHCHANDRAN ET AL.
ties were similar to those of JC7623 bearing unmutagenized pKA13Kan. Analogous results were obtained when the enzyme activities were measured in extracts of strain DM50 containing these plasmids. These results confirmed that the methionine-dependent growth phenotype observed in strain DM50 containing the plasmids is associated with mutations affecting metK. To investigate the nature of the mutations further, extracts prepared from cells grown at each temperature were incubated for 30 min at both growth temperatures before assay. Preincubation at 420C of the extract prepared from JC7623(pKA13Kan[metKS03]) grown at 30°C reduced the enzyme activity to that of cells grown at 42°C, indicating a reduction in protein stability of the mutant (data not shown). In contrast, the enzyme activity present in extracts of strains carrying plasmids pKA13Kan(metKS01) and pKA13Kan(metK502) was unaltered by preincubation at either 30 or 42°C, suggesting a temperature-dependent deficiency of protein quantity.
To examine a possible temperature-dependent alteration of in vivo AdoMet synthetase protein levels, extracts were electrophoresed on SDS-PAGE gels; after transfer of proteins to nitrocellulose, reactivity to anti-AdoMet synthetase antibodies was examined. At permissive temperature, AdoMet synthetase protein levels produced by all three mutant plasmids were similar to those of the parent plasmid, while much less protein was present at the nonpermissive temperature (data not shown). Immunoblotting results confirm the decreased protein quantity in strains carrying pKA13Kan(metK501) and pKA13Kan(metKS02) at the nonpermissive temperature. The reduced level at 42°C for the unstable metK protein in strains carrying pKA13Kan (metK503) is consistent with the failure of nonfunctional AdoMet synthetases produced from other mutant metK genes to accumulate to appreciable levels, apparently due to susceptibility to proteolysis in vivo (unpublished results).
Replacement of a c
s MetK with the temperaturesensitive mutants. The metK mutants described above were used to replace the chromosomal metK+ of strain JC7623 as described by Winans et al. (34) . An EcoRI-BalI restriction double digest of the mutant pKA13Kan-derived plasmids was performed, and the fragment containing metK was purified by agarose gel electrophoresis. The purified DNA was used to transform strain JC7623. Transformants were selected on medium containing kanamycin at the permissive temperature for the particular metK allele. Approximately 50 transformants were obtained in each case, and characterization of 25 individual isolates of each allele indicated that each behaved identically. When the kanamycin-resistant transformants were tested for growth at nonpermissive temperature, it was found that in no case did the transformants grow on the minimal medium which had previously supported growth at the permissive temperature. When the medium was supplemented with either methionine or vitamin B12, both metKS01 and metKS02 mutants grew normally at nonpermissive temperature, whereas no growth of metKS03 was observed at 42°C. Replacing methionine with homocysteine did not allow growth of metKS01 or metKS02 at the nonpermissive temperature. One isolate of each type was selected for firther characterization. To verify that the kanamycin resistance and temperaturesensitive growth were linked, and were associated with metK, bacteriophage P1 lysates were made on each strain and were used to transduce strain DM22 to kanamycin resistance. For each strain, all tested transductants (125 of 125) required methionine for growth even at the permissive temperature, as expected for a metK+ metG strain. Further- following temperature shift. The cells were grown overnight in limiting glucose (0.01%) in minimal medium containing amino acids and vitamin B12 at 30TC. The following day replicate cultures were replenished with glucose (0.2% final concentration) and were allowed to grow at 30 and 42°C for S h. Aliquots were withdrawn every hour for determination of AdoMet pools. The viable count determined for the wild type and the mutant strain when cultured at 30°C was 4 x 108 CFU/ml per A55 unit. more, the transductants displayed 20%o (24 of 125) cotransduction of the serA mutation to ser+, in good agreement with reported cotransduction frequencies of metK and serA (9) .
The introduction of mutations into the chromosomal copy of metK in strain JC7623 was also indicated by the elimination of temperature sensitivity for growth of mutant strains when they were transformed with a plasmid containing metK+ (e.g., pKA13Kan).
AdoMet synthetase activities nd itu
AMet levels In metK mutants. To examine the effects of the temperature-sensitive metK mutations on cell growth, each strain was grown to stationary phase at the permissive temperature and then diluted to -4 x 107 cells per ml into minimal medium at permissive and nonpermissive temperature. The three mutants behaved similarly, and a typical growth curve for strain metKS03 is shown in Fig. 2 . During growth, aliquots were removed for determination of the intracellular AdoMet level (Fig. 2) . The intracellular AdoMet levels decreased dramatically at nonpermissive temperature in each case. When growth had stopped, the AdoMet levels had reached 0.5% of wild type for the metKS01 and the metKS02 mutants and <0.2% of wild type for the metKS03 mutant. The temperature shift led to a profound decrease in AdoMet synthetase activity (data not shown). Immunoblots (Fig. 3) showed the disappearance of immunologically reactive protein at the nonpermissive temperature, as expected from the immunoblots with extracts of strains bearing mutant plasmids. When the medium was supplemented with methionine or vitamin B12, the metK501 and metKS02 mutants grew indefinitely at the same growth rate as the parent strain at both permissive and nonpermissive temperatures. In the presence of methionine or vitamin B12, the specific activity of the enzyme and the AdoMet levels were similar to that of the wild type at the permissive temperature, but were reduced to 4 and -0.5% of wild type, respectively, at the nonpermussive temperature ( Table 3 ). The presence of methionine or vitamin B12 did not allow metK503 to grow at the nonpermissive temperature, and AdoMet synthetase activity was undetectable (<1% of wild type) when growth stopped. The higher AdoMet pool sizes in strains metKS01 and metKS02, compared with that of a strain carrying metKS03, of wild-type and mutant strains grown in minimal medium at permissive and nonpermissive temperatures. Extracts were prepared from cells cultured as described (see Materials and Methods), while for the mutant metK503 the cells were cultured as described in the legend to Fig. 2 . Equivalent amounts of protein (-100 rag) of each extract and -0.3 ,ug of purified AdoMet synthetase (metK gene product) were electrophoresed on a 17.5% SDS-polyacrylamide gel.
Numbers on the right correspond to the molecular mass in kilodaltons of the prestained protein standards. Lanes and the small amounts of enzyme activity in extracts of these mutants suggested that there might be slight AdoMet synthetase activity produced from metK in these mutants at nonpermissive temperature. To test this hypothesis, strains containing these mutations were transformed with the pKA13Kan derivatives containing the same mutations: pKA13Kan(metKS01) was transformed into metK501; pKA13Kan(metK502), into metKS02; and pKA13Kan (metSO3), into metKS03. When the mutant metK genes were also present on a multicopy plasmid, temperature-sensitive growth phenotypes were not observed for either the metK501 or metK502 mutants, while the temperature-sensitive growth of the metKS03 mutant was unaltered. These a Cells (JC7623 and mutants derived from it) were grown to stationary phase overnight in Vogel-Bonner medium containing appropriate amino acids and vitamin B12, but limiting (0.01%) glucose. These cultures were made up in glucose concentrations (0.2%), and replicate cultures were incubated at 30 and 42'C. The cells were harvested at late log phase. The metK503 mutant was harvested when growth stopped. Kanamycin was included in the growth medium of metK mutant strains. The uncertainties in enzyme activity and AdoMet pool sizes are estimated to be ± 10 and ±20%, respectively. results indicate that the metK501 and metK502 mutations are leaky at the nonpermissive temperature, while the metK503 is not detectably so.
Properties of mutants. As noted above, even with 0.5% of the wild-type intracellular AdoMet level, the metK501 and metK502 mutants showed normal growth rates in medium supplemented with either methionine or vitamin B12. Since homocysteine did not replace methionine for growth, a deficiency in methionine synthesis is suggested at its final biosynthetic step, which can occur through either AdoMetor vitamin B12-dependent enzymes, the metE and metH gene products, respectively (29) .
AdoMet synthetase activities and intracellular AdoMet levels in metK mutants grown in rich media. The temperaturesensitive phenotype of the metK503 mutant was not observed during growth on rich medium (LB medium). Therefore, AdoMet synthetase activities and AdoMet pool sizes were determined for cells grown at 30 and 42°C in LB medium. The AdoMet pools and AdoMet synthetase activities in extracts of the wild-type and all mutant strains were similar at 30 and 42°C growth temperatures (Table 4 ). Immunoblot analysis (using antiserum against the metK gene product) of the wild type and of the mutant extracts prepared from LB-grown cells at either permissive or nonpermissive temperature showed a cross-reactive protein of -43 kilodaltons ( Fig. 4 ), indistinguishable in migration from the metK gene product. These results are consistent with a 43-kilodalton isozyme of AdoMet synthetase being predominantly expressed in rich media.
Immunodiffusion analysis of extracts of strains grown in rich media. Although the two forms of AdoMet synthetases were indistinguishable on denaturing polyacrylamide gels ( Fig. 4) , immunodiffusion experiments ( Fig. 5 and 6 ) showed the presence of two distinct forms of immunologically related protein, depending on the medium in which cells had been grown. In extracts of wild-type and mutant strains prepared from cells grown in rich media at either 30 or 42°C, immunoprecipitin bands were observed distinct from those of purified AdoMet synthetase (metK gene product) ( Fig. 5 ). In minimal media, both the mutant cultured at permissive temperature and the wild-type cell extracts showed immunoprecipitin bands with identity to the purified metK protein (Fig. 6 ). However, precipitin bands were not observed in extracts of mutants cultured in minimal media at the nonpermissive temperature, as expected from the immunoblotting results (Fig. 3 ). In no case were both immunoprecipitin bands seen in the same extract. These results present evidence for the presence of another gene that encodes an VOL. 172, 1990 4494 SATISHCHANDRAN ET AL. Immunoblot analysis of SDS-PAGE-separated extracts of wild-type and mutant strains cultured in rich medium (LB) at permissive and nonpermissive temperatures. The cells were grown overnight to stationary phase, and extracts were prepared and electrophoresed as described in the legend to Fig. 3 and immunoblotted (see Materials and Methods). Lanes 1 to 9 are also as described in the legend to Fig. 3 . alternate form of AdoMet synthetase which can be distinguished in its native form from the AdoMet synthetase encoded by the metK gene; we denote this gene metX.
DISCUSSION
The metK mutants constructed in this study confer novel growth phenotypes even in the absence of other mutations in methionine metabolism. Previously obtained metK mutants were selected by resistance to methionine analogs, due to the overproduction of methionine. Although none of the previous mutants displayed a distinct phenotype, altered A growth requirements resulting from introduction of these metK mutations into either metG (6) or metA strains (18) have been described. When the previously reported metK mutations were introduced into metG strains, the methionine overproduction due to the metK mutation complemented the high Km for methionine of the mutant metG protein, methionyl-tRNA synthetase (6) . When these previous metK mutations were introduced into metA strains, temperature-sensitive metA metK double mutants grew in the presence of methionine but not cystathionine at the nonpermissive temperature (18) . The differences in phenotypes between the previously described metK mutants and the mutants we have examined probably results from the residual enzyme activity of previously described metK mutants, which had, minimally, a few percent of wild-type activity and, maximally, a fourfold-reduced intracellular AdoMet level (2, 10, 17, 18) . It is the reduction of residual enzyme activity to a much lower level that has enabled us to demonstrate distinct phenotypes in the present set of mutants. The selection we have used is more stringent because of the higher copy number of the plasmid-borne gene, which allows the isolation of metK mutants which contain AdoMet synthetase activities at much lower levels than reported previously. It is not clear at present whether the AdoMet synthetase activity found in previous metK mutants in minimal media arises from a leaky metK mutation or from abnormal expression of the metX gene.
Our two mutants with slight (-3%) residual AdoMet synthetase activity, metK501 and metK502, have an -200fold reduction in AdoMet pool size at nonpermissive temperatures. The surprising failure of the strains to grow at the nonpermissive temperature in the absence of either methionine or vitamin B12, and their growth at the wild-type rate in the presence of either of these compounds, suggests that the major role of AdoMet is in the final step of methionine biosynthesis, the methylation of homocysteine to yield methionine. The cessation of growth of the metK503 mutant at the nonpermissive temperature, even in strains that carry the plasmid with the corresponding mutation, is related to the B FIG. 5. Immunodiffusion analysis of sonic extracts of wild-type and mutant strains cultured in rich medium (LB) at permissive and nonpermissive temperatures. The cells were grown and the extracts were prepared as described in the legend to Fig. 4 . The center well contained 10 ,ul of antiserum. The sample wells contained 10 p.1 of sonic extracts of cells or 10 ,ul of purified metK gene product (0.1 mg/ml). The immunodiffusion plates were incubated overnight at 4°C. Numbers 1 to 9 correspond to the lanes described in the legend to Fig. 3 .
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FIG. 6. Immunodiffusion analysis of sonic extracts of wild-type and mutant strains cultured in minimal medium at permissive and nonpermissive temperatures. The cells were grown and the extracts were prepared as described in the legend to Fig. 3 . The immunodiffusion was performed as described in the legend to Fig. 5 , and numbers 1 to 9 correspond to the lanes described in the legend Fig. 3. depletion of AdoMet or AdoMet synthetase activity or both. This critical intracellular AdoMet level is <0.2% of wild type. The metK503 mutant does not grown at the nonpermissive temperature even in the presence of methionine and B12, consistent with a requirement for AdoMet in processes that cannot be satisfied when the AdoMet levels are significantly reduced from those present in metK501 and metK502 mutants. This suggested role of AdoMet in other cellular processes is consistent with the observation that the metK503 mutant strain was not viable after shift of growth temperature from 30 to 42°C in minimal medium. The impermeability of E. coli to AdoMet has prevented the demonstration that AdoMet alone is sufficient to restore growth of the metK503 mutant. It is noteworthy that, of the eluant peaks observed in the cation-exchange high-performance liquid chromatograms, only changes in AdoMet, S-adenosylhomocysteine, and 5'-methioadenosine levels were observed when mutants at nonpermissive temperatures were compared with wild-type controls. Therefore, it appears that nucleoside metabolism may not be grossly altered upon AdoMet depletion. The nutritional provision derived from a rich medium by the metK503 mutant and its role remain elusive. None of the amino acid or vitamin supplements we have tested have substituted for the yeast extract component of Luria broth. However, these new metK mutants in minimal media should provide useful tools for the investigation of the levels of AdoMet required for various metabolic pathways as well as the appropriate background for the construction and characterization of mutations in AdoMet synthetase.
Coincidentally, these studies have led to the discovery of another AdoMet synthetase which apparently is normally expressed only in rich media; we have denoted the gene which encodes this isozyme metX. The metX gene product shares antigenic similarity to the metK-encoded AdoMet synthetase. Preliminary DNA hybridization experiments show a second chromosomal restriction fragment that hybridizes to metK, and we attribute this to metX. Studies directed toward cloning and mapping of the metX gene are in progress.
